Division News

Helping Women with Rheumatic Disease Have Families

In her clinic, Megan Clowse, MD, MPH, associate professor of medicine (Rheumatology and Immunology), helps patients with rheumatic disease safely navigate pregnancy while managing their disease. In her research, she gathers and analyzes data about the best pregnancy planning and management practices. She’s also working to educate providers and patients on a larger scale.

“I’m trying to figure out how everyone can get state-of-the-art care from their local rheumatologist in order to have healthy pregnancies,” she says. “My mission is that all women with rheumatic disease can have the families they want.”

Rheumatic Diseases and Pregnancy: Should HCQ Dose Change in Pregnancy?

For women who take hydroxychloroquine (HCQ) to control rheumatic disease, research has shown that it’s best for mother and baby to continue the medicine during pregnancy. But should the dose be maintained, decreased, or increased? Stephen Balevic, MD, assistant professor of pediatrics and medicine (Rheumatology and Immunology), set out to investigate this question using data from the Duke Autoimmunity in Pregnancy registry. 

Rheumatic Diseases and Pregnancy: How do Outcomes Correlate to Patient-Reported Measures?

When a woman with rheumatic disease is pregnant, she may experience many symptoms--some from her underlying disease and some from pregnancy itself. Which of these symptoms signal increased risk for preterm delivery?

Nathaniel Harris, MD, PhD, an intern in the Duke internal medicine residency program, spent his third year of medical school, also at Duke, plumbing the DAP registry for insights into this question.